In a meta-analysis of 23 studies on tumor infiltrating lymphocytes (TILs), Gooden et al. observed that the presence of CD8+ TILs resulted in a prognostic advantage for all survival endpoints tested [19]. This evidence concerns the gene CD8A and neoplasm.